Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Tissues from patients thought to have Epstein-Barr virus (EBV)-induced lymphoproliferative diseases were probed for EBV genomes using 2 independent hybridization techniques. Tissues from six patients with the X-linked lymphoproliferative syndrome, all five renal allograft recipients with immunoblastic sarcoma, and eight patients with diverse types of immunodeficiency and lymphoproliferative diseases such as fatal infectious mononucleosis or malignant lymphoma associated with antecedent immunodeficiency contained significant numbers of EBV genome equivalents per cell. The use of 2 hybridization probes is recommended to confirm the presence of EBV genomes. The finding of significant numbers of EBV genomes in tissues from patients with immunodeficiency suggests that EBV is the etiological agent of the associated lymphoproliferative diseases.
D000293:Adolescent; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004279:DNA, Viral / Q000302:isolation & purification; D005814:Genes, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics* / Q000648:ultrastructure; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000382:microbiology*; D007244:Infectious Mononucleosis / Q000276:immunology / Q000382:microbiology; D008198:Lymph Nodes / Q000648:ultrastructure; D008223:Lymphoma / Q000276:immunology / Q000382:microbiology; D008232:Lymphoproliferative Disorders / Q000276:immunology / Q000382:microbiology*; D008875:Middle Aged; D009693:Nucleic Acid Hybridization; D012367:RNA, Viral / Q000302:isolation & purification; D014412:Tumor Virus Infections / Q000276:immunology / Q000382:microbiology*
D004279:DNA, Viral; D012367:RNA, Viral